UnitedHealth Group Incorporated (NYSE:UNH) Position Trimmed by First Eagle Investment Management LLC

First Eagle Investment Management LLC lessened its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 90.3% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 40,041 shares of the healthcare conglomerate’s stock after selling 372,133 shares during the quarter. First Eagle Investment Management LLC’s holdings in UnitedHealth Group were worth $20,255,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Howard Capital Management Group LLC acquired a new stake in shares of UnitedHealth Group during the 3rd quarter valued at about $341,000. Principal Financial Group Inc. lifted its holdings in shares of UnitedHealth Group by 11.3% during the 3rd quarter. Principal Financial Group Inc. now owns 1,778,636 shares of the healthcare conglomerate’s stock valued at $1,039,933,000 after buying an additional 180,479 shares during the last quarter. Cable Hill Partners LLC lifted its holdings in shares of UnitedHealth Group by 22.2% during the 3rd quarter. Cable Hill Partners LLC now owns 2,687 shares of the healthcare conglomerate’s stock valued at $1,571,000 after buying an additional 488 shares during the last quarter. Plato Investment Management Ltd lifted its holdings in UnitedHealth Group by 4.8% in the 3rd quarter. Plato Investment Management Ltd now owns 23,266 shares of the healthcare conglomerate’s stock worth $13,589,000 after purchasing an additional 1,070 shares during the last quarter. Finally, Fortis Capital Management LLC lifted its holdings in UnitedHealth Group by 4.2% in the 3rd quarter. Fortis Capital Management LLC now owns 8,920 shares of the healthcare conglomerate’s stock worth $5,216,000 after purchasing an additional 357 shares during the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Insiders Place Their Bets

In other UnitedHealth Group news, Director Timothy Patrick Flynn purchased 1,000 shares of the stock in a transaction on Friday, January 17th. The stock was bought at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the acquisition, the director now directly owns 4,500 shares of the company’s stock, valued at $2,302,065. The trade was a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 0.33% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts have recently commented on the company. Oppenheimer upped their price target on UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a report on Friday, December 6th. Hsbc Global Res upgraded UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a report on Friday, January 10th. Truist Financial cut their price target on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a report on Monday, January 6th. Wells Fargo & Company lowered their price objective on UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating on the stock in a research report on Tuesday, January 28th. Finally, Cantor Fitzgerald restated an “overweight” rating and set a $700.00 price objective on shares of UnitedHealth Group in a research report on Friday, January 17th. Twenty investment analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Buy” and an average target price of $629.32.

UnitedHealth Group Trading Down 0.1 %

NYSE:UNH opened at $480.79 on Friday. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $630.73. The business’s 50-day moving average price is $511.85 and its two-hundred day moving average price is $551.01. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The firm has a market capitalization of $439.78 billion, a price-to-earnings ratio of 31.02, a PEG ratio of 1.37 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. During the same quarter in the prior year, the firm posted $5.83 earnings per share. The company’s quarterly revenue was up 6.8% on a year-over-year basis. On average, equities analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th will be issued a $2.10 dividend. The ex-dividend date is Monday, March 10th. This represents a $8.40 annualized dividend and a dividend yield of 1.75%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 54.19%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.